MRI‐based intravenous thrombolysis in stroke patients with unknown time of symptom onset

Background:  Currently, stroke patients with unknown time of symptom onset (UTOS) are excluded from therapy with intravenous tissue Plasminogen Activator. We hypothesized that MRI‐based intravenous thrombolysis is safe in UTOS.

[1]  青木 淳哉 Intravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time , 2013 .

[2]  K. Kimura,et al.  Intravenous Thrombolysis Based on Diffusion-Weighted Imaging and Fluid-Attenuated Inversion Recovery Mismatch in Acute Stroke Patients with Unknown Onset Time , 2011, Cerebrovascular Diseases.

[3]  Gregory W Albers,et al.  Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials , 2010, The Lancet.

[4]  A. Doerfler,et al.  Feasibility and Safety of Magnetic Resonance Imaging-Based Thrombolysis in Patients with Stroke on Awakening: Initial Single-Centre Experience , 2010, International Journal of Stroke.

[5]  K. Furie,et al.  Wake-Up Stroke: Clinical and Neuroimaging Characteristics , 2010, Cerebrovascular Diseases.

[6]  Arno Villringer,et al.  Prospective study on the mismatch concept in acute stroke patients within the first 24 h after symptom onset - 1000Plus study , 2009, BMC neurology.

[7]  C. Gerloff,et al.  Negative fluid‐attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less , 2009, Annals of neurology.

[8]  J. Grotta,et al.  Thrombolytic Therapy for Patients Who Wake-Up With Stroke , 2009, Stroke.

[9]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.